Sophie Caillat-Zucman

22PUBLICATIONS
119CO-AUTHORS
HaematologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Host-parasite interactionsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Dec 10, 2025
Harnessing HLA Divergence for Improved Donor Selection in Haploidentical Haematopoietic Stem Cell Transplantation.

Debora Jorge Cordeiro, Juliette Villemonteix, Alienor Xhaard

|Nov 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Agathe Carrier, Paolo Manghi, Carolina Alves Costa Silva

|Mar 28, 2025
Lymphodepletion chemotherapy in chimeric antigen receptor-engineered T (CAR-T) cell therapy in lymphoma.

Marta Canelo-Vilaseca, Mohamad Sabbah, Roberta Di Blasi

|Mar 05, 2025
Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation.

Mathieu F Chevalier, Vincent Allain, Julien Gras

|Feb 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.

Sophie Le Grand, Juliette Villemonteix, Etienne Daguindau

|Sep 24, 2024
Neurofilament light chain levels as an early predictive biomarker of neurotoxicity after CAR T-cell therapy.

Marion Larue, Amélie Bouvier, Alexis Maillard

Pageof 4

Frequent Collaborators

6 joint publications

Mathieu F Chevalier

4 joint publications

Jean-Luc Taupin

4 joint publications

Juliette Villemonteix

4 joint publications

Vincent Allain